| __timestamp | CRISPR Therapeutics AG | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5114000 | 9335772 |
| Thursday, January 1, 2015 | 13403000 | 12390000 |
| Friday, January 1, 2016 | 31056000 | 25602000 |
| Sunday, January 1, 2017 | 35845000 | 21262000 |
| Monday, January 1, 2018 | 48294000 | 28430000 |
| Tuesday, January 1, 2019 | 63488000 | 40849000 |
| Wednesday, January 1, 2020 | 88208000 | 60210000 |
| Friday, January 1, 2021 | 102802000 | 83664000 |
| Saturday, January 1, 2022 | 102464000 | 104097000 |
| Sunday, January 1, 2023 | 76162000 | 106916000 |
| Monday, January 1, 2024 | 72977000 |
Cracking the code
In the rapidly evolving biotech sector, understanding financial trends is crucial. Over the past decade, CRISPR Therapeutics AG and Iovance Biotherapeutics, Inc. have shown significant shifts in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, CRISPR Therapeutics AG's SG&A expenses surged by over 1,300%, peaking in 2021. Meanwhile, Iovance Biotherapeutics, Inc. experienced a 1,000% increase, with a notable rise in 2023. This trend reflects strategic investments in research and development, marketing, and administrative capabilities. Notably, both companies saw their highest expenses in the last three years, indicating a competitive push in the biotech landscape. As these companies continue to innovate, monitoring their financial strategies offers insights into their market positioning and future growth potential.
Biogen Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or CRISPR Therapeutics AG
TG Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? CRISPR Therapeutics AG or Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: CRISPR Therapeutics AG vs Wave Life Sciences Ltd. Trends and Insights
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Galapagos NV
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Iovance Biotherapeutics, Inc.